Search Results 991-1000 of 25339 for Pulmonary
Study of Tozorakimab to Treat Chronic Obstructive Pulmonary Disease (COPD) with a History of Exacerbations ... pulmonary disease (COPD) exacerbation in former ...
Mayo Clinic researchers recently learned that patients who are taking antifibrotic drugs for idiopathic pulmonary fibrosis (IPF) have a better chance of ...
Oncology (Medical) · Palliative Care in Minnesota · Pediatric Hematology/Oncology · Proton Beam Therapy Program · Pulmonary Medicine · Radiation Oncology ...
Expanded Access Program (EAP): Allow Patients in the US with Idiopathic Pulmonary Fibrosis Access to Pirfenidone · Overview · Participation eligibility.
Mayo Clinic researcher Yewande Odeyemi, M.B.B.S., studies acute pulmonary inflammation, including community acquired pneumonia and acute respiratory ...
Teacher of the Year-- Pulmonary & Critical-Care MedicineMayo Fellows Association, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine ...
More-complete pulmonary function tests can measure the amount of oxygen being transferred to your bloodstream. Diagnostic procedures. In some situations, your ...
... pulmonary arterial hypertension (PAH). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...
Pulmonary, Critical Care, and Sleep Medicine · Referrals · News · Videos · Physicians · Continuing EducationExternal Link · Clinical Trials. Research aims to ...
Pulmonary fibrosis — a disease that happens when lung tissue becomes damaged and scarred. Sleep apnea — a condition in which breathing stops and starts many ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.